| Walgreens Pharmacy 03204 | |
| 295 Academy Ave, Providence, Rhode Island 02908 | |
| (401) 273-7675 |
| Name | Walgreens Pharmacy 03204 |
|---|---|
| Organization Name | Walgreen Eastern Co Inc |
| Location | 295 Academy Ave, Providence, Rhode Island 02908 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (401) 273-7675 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Regenerative medicine company Mesoblast Limited (ASX: MSB) today announced that it has received regulatory clearance from the Singapore Health Sciences Authority (HSA) to commence the first Phase 2 trial of its proprietary allogeneic (off-the-shelf) adult stem cell therapy for patients with proliferation of leaky blood vessels in the eyes – neovascular ("wet") Age-related Macular Degeneration (AMD).
Middle Peak Medical, a development-stage medical device company that will commercialize a novel technology for treating mitral valve disease, has raised an additional $3M in a second closing of its over-subscribed Series A financing, which now totals approximately $11M.
In a new study available on the preprint server Preprints*, researchers have innovated a transparent face shield with intrinsic antimicrobial activity.
A new emergency department study from the University of Michigan Injury Center looks deeper at risk and protective factors among teenagers who report dating violence and alcohol use.
Northrop Grumman Corporation has begun deliveries of critical assay technology to the U.S. Department of Homeland Security as part of the company's BioWatch Gen-3 contract to develop a new generation of biological detectors for homeland defense applications.
› Verified 9 days ago
| NPI Number | 1831104900 |
| Organization Name | WALGREEN EASTERN CO INC |
| Doing Business As | WALGREENS #03204 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 295 Academy Ave, Providence, RI 02908 |
| Phone Number | 401-273-7675 |
News Archive
Regenerative medicine company Mesoblast Limited (ASX: MSB) today announced that it has received regulatory clearance from the Singapore Health Sciences Authority (HSA) to commence the first Phase 2 trial of its proprietary allogeneic (off-the-shelf) adult stem cell therapy for patients with proliferation of leaky blood vessels in the eyes – neovascular ("wet") Age-related Macular Degeneration (AMD).
Middle Peak Medical, a development-stage medical device company that will commercialize a novel technology for treating mitral valve disease, has raised an additional $3M in a second closing of its over-subscribed Series A financing, which now totals approximately $11M.
In a new study available on the preprint server Preprints*, researchers have innovated a transparent face shield with intrinsic antimicrobial activity.
A new emergency department study from the University of Michigan Injury Center looks deeper at risk and protective factors among teenagers who report dating violence and alcohol use.
Northrop Grumman Corporation has begun deliveries of critical assay technology to the U.S. Department of Homeland Security as part of the company's BioWatch Gen-3 contract to develop a new generation of biological detectors for homeland defense applications.
› Verified 9 days ago
News Archive
Regenerative medicine company Mesoblast Limited (ASX: MSB) today announced that it has received regulatory clearance from the Singapore Health Sciences Authority (HSA) to commence the first Phase 2 trial of its proprietary allogeneic (off-the-shelf) adult stem cell therapy for patients with proliferation of leaky blood vessels in the eyes – neovascular ("wet") Age-related Macular Degeneration (AMD).
Middle Peak Medical, a development-stage medical device company that will commercialize a novel technology for treating mitral valve disease, has raised an additional $3M in a second closing of its over-subscribed Series A financing, which now totals approximately $11M.
In a new study available on the preprint server Preprints*, researchers have innovated a transparent face shield with intrinsic antimicrobial activity.
A new emergency department study from the University of Michigan Injury Center looks deeper at risk and protective factors among teenagers who report dating violence and alcohol use.
Northrop Grumman Corporation has begun deliveries of critical assay technology to the U.S. Department of Homeland Security as part of the company's BioWatch Gen-3 contract to develop a new generation of biological detectors for homeland defense applications.
› Verified 9 days ago
Cvs Pharmacy #02293 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2 Dudley St, Providence, Rhode Island 02905 Phone: (401) 421-1555 | |
Cvs Pharmacy #00994 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 131 Webster Ave, Providence, Rhode Island 02909 Phone: (401) 944-6060 | |
Cvs Pharmacy #01294 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 481 Angell St, Providence, Rhode Island 02906 Phone: (401) 521-4340 | |
Cvs Pharmacy #00729 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 799 Hope St, Providence, Rhode Island 02906 Phone: (401) 331-5240 | |
Cvs Pharmacy #00856 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 400 Admiral St, Providence, Rhode Island 02908 Phone: (401) 351-5030 |